Flagship merger ‘effectively scrapped’ after ‘wasting millions’

By Lawrence Dunhill2023-02-10T12:38:00

The leader of a flagship ‘hub and spoke’ pathology merger has criticised regulators after the project was effectively dropped due to delays in receiving £31m of capital that was allocated to the scheme in 2018.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here